KALA News and Press, Kala Pharmaceuticals Inc.

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is one of today's top gainers. The company's shares have moved 44.91% on the day to $6.55. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus pe...

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...

2024-06-27 09:06:34 ET More on Kala Pharmaceuticals Seeking Alpha’s Quant Rating on Kala Pharmaceuticals Historical earnings data for Kala Pharmaceuticals Financial information for Kala Pharmaceuticals Read the full article on Seeking Alpha For...

ARLINGTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that it has entered into a sec...

2024-06-01 04:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ARLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that Kim Brazzell, Ph.D., Head ...

2024-05-22 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-17 12:00:04 ET Yi Chen from H.C. Wainwright issued a price target of $18.00 for KALA on 2024-05-17 10:34:00. The adjusted price target was set to $18.00. At the time of the announcement, KALA was trading at $6.5. The overall price target consensus is at $21.00 wi...

2024-05-14 17:05:24 ET More on Kala Pharmaceuticals Kala Pharmaceuticals GAAP EPS of -$3.18 beats by $0.44 Seeking Alpha’s Quant Rating on Kala Pharmaceuticals Historical earnings data for Kala Pharmaceuticals Financial information for Kala Pharmaceuti...